Windlas Biotech Gets CDSCO Panel Nod To study Bisoprolol Fumarate, Telmisartan, Chlorthalidone FDC Dr. Divya Colin26 March 2025 6:15 PM ISTNew Delhi: Windlas Biotech has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron Dr. Divya Colin14 March 2025 4:00 PM ISTNew Delhi: Responding to the revised Phase III clinical trial protocol of fixed dose combination (FDC) Tamsulosin plus MirabegronIP 0.4 mg/0.4 mg +...
Revise Phase III CT Protocol:Â CDSCO Panel Tells Windlass Biotech on FDC Tamsulosin Hydrochloride plus Mirabegron Dr. Divya Colin15 Aug 2024 5:00 PM ISTNew Delhi: In response to the proposal presented by the drug maker Windlass Biotech, the Subject Expert Committee (SEC) functional under the Central...
Justify Sample Size: CDSCO Panel Tells Windlas Biotech on Cardiovascular FDC Dr. Divya Colin19 May 2024 5:45 PM ISTNew Delhi: Reviewing the bioequivalence (BE) study report of the fixed-dose combination (FDC) of cardiovascular drug Bisoprolol Fumarate...
Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug Dr. Divya Colin1 Oct 2022 5:00 PM ISTNew Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
NPPA fixes price of 84 formulations, revises 1 Ruchika Sharma13 May 2022 3:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 84 formulations and has...
NPPA fixes retail price of 19 formulations, Details Susmita Roy25 Feb 2022 3:23 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
NPPA panel fixes retail price of Torrent Pharma Atorvastatin, Clopidogrel Bisulphate, Aspirin FDC Medical Dialogues Team14 Dec 2021 7:09 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of hard gelatin capsule containing Atorvastatin...
Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
Health Bulletin 8 / November /2021 Roshni Dhar8 Nov 2021 4:53 PM ISTHere are Top Health Stories of the day Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with ...
HC restrains 4 pharma firms from making, selling Novartis Sacubitril, Valsartan tablets Ruchika Sharma2 Nov 2021 6:09 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or...
Cadila Healthcare to sell 49 pc stake in WHPL to Windlas Biotech for Rs 99.44 cr Ruchika Sharma3 May 2020 1:00 PM ISTNew Delhi: Drug firm Cadila Healthcare on Thursday said it has signed a definitive pact to sell its 49 per cent stake in Windlas Healthcare to Windlas...
